Featured White Papers
- 5 Strategies for Making Sales the Engine for Growth (AchieveGlobal)
- Hosted CRM buyer's guide (Inside CRM)
- Hosted CRM comparison guide (Inside CRM)
PR Newswire
Articles in May 31, 2008, issue of PR Newswire
- 13-year-old Indiana Boy Wins Scripps National Spelling Bee
- VELCADE® for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
- Phase III Study of Abbott's Investigational TriLipix™ in Combination With AstraZeneca's CRESTOR® Meets Primary Endpoints on Key Lipids
- Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
- THUNDER FROM DOWN UNDER Tour Van Stolen
- Spike TV Announces 2008 'Guys Choice' Winners
- New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
- Update: Water Park Thrills at Jaw-Dropping Prices
- Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
- Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
- Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara® for the Treatment of Brain Cancer
- Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
- Las Vegas Sands Corp. to Present at the Goldman Sachs Lodging, Gaming, Restaurant and Leisure Conference
- New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
- Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa® in Women With Early-Stage Breast Cancer
- Water Park Thrills at Jaw-Dropping Prices
- Quipp Announces Definitive Acquisition Price in Merger Agreement with Illinois Tool Works Inc
- Standard Pacific Corp. Provides Notice to Holders of 6% Convertible Senior Subordinated Notes Due 2012
- Following Is a Test Release
- Multiple Clinical Trials of VELCADE® for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
- Terrawest commits to drilling of up to 3 CBM wells in its Junggar Liuhuanggou PSC